Gastric Electrical Stimulators Market

Gastric Electrical Stimulators Market Outlook (2023 to 2033)

The global gastric electrical stimulator market size is estimated to reach a valuation of USD 240.6 million in 2023. The market of gastric electrical stimulators is projected to record a robust CAGR of 6.1% between 2023 and 2033, totaling around USD 433.8 million by 2033.

The infusion of cutting-edge high-frequency stomach electrical stimulators and an enormous difference in managing chronic illnesses such as gastroparesis are expected to transform the market landscape.

Factors Fueling the Growth of the Gastric Electrical Stimulators Market

• Rising Gastroparesis Prevalence: According to the National Institute of Health, an estimated five million people in the United States were affected by delayed gastric emptying in 2022. Moreover, a study conducted in 2020 found that patients with type 1 diabetes are more prone to gastroparesis, which is 5.2% compared to type 2 diabetes, which is 1%.
• Focus on Minimally Invasive Surgery: In GES therapy, emphasis is placed on minimally invasive methods. When carried out in non-hospital settings, this therapy is more appealing to patients and is positioned as a good substitute for standard surgical treatments for gastroparesis.
• Influence of the Elderly Population: The dynamics of demand are significantly shaped by the geriatric demography. This segment's expansion increases the demand for GES therapy because of their increased susceptibility to gastroparesis. A corresponding rise in demand for these procedures is unavoidable as the population ages.
• Technological Advances: GES technology has advanced significantly in recent years. GES devices can control the symptoms such as nausea and reduce the frequency of vomiting. These developments have increased the GES therapy's effectiveness and safety, establishing a transformative environment.

This interaction of variables produces a dynamic tapestry that drives market growth and emphasizes a journey driven by medical necessity and technological advancement.

A defining feature is an ongoing increase in gastroparesis prevalence, a chronic condition that impairs natural stomach emptying. An epidemiologic study conducted in Europe in 2022, estimated that the incidence of gastroparesis is 1.9 per one thousand person-years. Gastric electrical stimulators (GES) are expected to see a commensurate rise in demand as they become more common, placing them at the forefront of cutting-edge therapeutic approaches.

Data Points	Key Statistics
Gastric Electrical Stimulators Market Size (2023)	USD 240.6 million
Gastric Electrical Stimulators Market Revenue Forecast (2033)	USD 433.8 million
Gastric Electrical Stimulators Market Growth Rate (2023 to 2033)	6.1% CAGR

The Wave of Exponential Growth in the Market

Attributes	Details
Increasing Prevalence of Gastroparesis	The prevalence of gastroparesis is increasing among elderly, highlighting the urgent need for cutting-edge therapies and putting research and development projects front and center. Given that older people, diabetic and obese people are more susceptible to this, a corresponding increase is expected in demand for GES therapy to meet the changing healthcare requirements.
Reimbursement Policy	The atmosphere benefits from the reassuring presence of supportive reimbursement regulations, creating a situation conducive to treatment accessibility. The GES therapy reimbursement environment in the United States shows a positive trend. Medicare and other commercial insurance companies support paying for GES therapy expenses. Due to the patients' increased access to affordable treatment alternatives, there is an increase in demand due to this financial support.
High-frequency GES	The success rate of high-frequency gastric electrical stimulators in treating the complicated issues caused by gastroparesis is contributing to their growth. Compared to their conventional counterparts, high-frequency GES devices can deliver electrical pulses faster, and this capacity has allowed them to carve out a distinct market niche. The efficient stimulation of the stomach muscles enabled by this increased frequency greatly speeds up gastric emptying.

Investment Opportunities in the Industry

• Innovative Device Developers: Invest in businesses creating cutting-edge GES devices, which stimulate market expansion through efficiency and usability. Businesses broadening their GES products present prospects in a developing therapeutic landscape, particularly for obesity and diabetes.
• Global Expansion Players: Firms should invest in medical device companies that are bringing the GES technology into developing countries to capitalize on unrealized growth potential.
• Wireless Gastric Stimulation Devices: Increasing need for early diagnosis and preventive treatments are making IoT a hotbed of innovation in medical industry. The technology is used to relieve the symptoms of gastroparesis and medication use. Companies should invest in innovators and vendors that are involved in the application of wireless GES devices.

Country-wise Insights

Country	The United States
Market Share 2023	55%

The United States is at the Forefront of Innovation in North America

With a sizable 55% market share, the United States emerges as the global leader for gastric electrical stimulators. Due to its sophisticated healthcare system, significant investments in medical research and technology have been made. Due to high prevalence of illnesses requiring gastric electrical stimulators, the United States has gained a lot of attention. The nation's progressive regulatory environment and helpful reimbursement rules encourage the adoption of cutting-edge medical solutions like GES and further reinforce its top ranking.

Countries	CAGR 2023 to 2033
India	8.5%
China	8.1%
Japan	7.2%

Japan is Diving in Medical Technology with a Pioneering Growth of 7.2%

Gastric electrical stimulators market in Japan is anticipated to register a noteworthy 7.2% compound annual growth rate from 2023 to 2033, as it embarks on a trajectory of innovation. Japan is well-positioned to redefine treatment interventions for illnesses like gastroparesis, propelled by its technological prowess. The nation is a front-runner in influencing the development of gastric electrical stimulators due to its dedication to promoting healthcare solutions and careful research methodology.

Embracing New Healthcare Technology Trends in India

India has a significant presence in the gastric electrical stimulators market with an 8.5% CAGR. This can be linked to increased healthcare spending, increased healthcare awareness across the country, and an increase in disorders requiring GES therapy. India's notable position in the market results from the country's expanding middle-class population and better access to healthcare.

The Future of Healthcare is Changing in China with Advanced Technology

A strong CAGR of 8.1% sheds light on China's presence in the global market for stomach electrical stimulators. This accomplishment is proof of the country's rapid technological advancement and dynamic healthcare evolution.

China's increased focus on medical innovation has strengthened its position in the area of GES. Through the seamless integration of cutting-edge medical technologies, the country is replacing traditional treatments with tiny wireless stimulators. This places China as a powerful force in gastric electrical stimulation with better therapy options.

Category-wise Insights

Category	Product Type
Leading Segment	High-frequency GES Devices
Market Share	77.5%

Category	Indication
Leading Segment	Gastroparesis
Market Share	33.2%

• High-frequency GES devices segment holds a sizeable market share of 77.5%, based on type. These devices stand out from their conventional counterparts. It increases their effectiveness in activating stomach muscles and promoting effective gastric emptying.
• As per our FMI’s researcher, the hospital segment may account for the lion's market share between 2023 and 2033. Growing adoption of improved gastroparesis treatment technologies and increased development of surgical instrum
• ents and robotics for gastric stimulator surgeries across hospitals are expected to favor segment growth.

The Dynamic Landscape in the Start-up Ecosystem

Manufacturers are adopting various marketing strategies such as new product launches, geographical expansion, mergers and acquisitions, partnerships, and collaboration to identify the interests of potential buyers and create a larger customer base. For instance,

• IntraPace Inc. was established in 2001 to address an unmet need in weight loss surgery by continuing to develop a gentler solution. The company is focusing on gastric pacing devices that use electrical stimulation to influence gut contractions.

Key Developments

• Medtronic teamed up with Google, a leader in artificial intelligence, to use AI to improve gastric electrical stimulators. This partnership aims to create a cutting-edge stimulator that can adjust to the needs of each patient, potentially revolutionizing the effectiveness and personalization of treatment.
• The INSPIRIS Control wireless stomach electrical stimulator, introduced by IntraPace in 2021, represented a significant advance in patient-centered technology. This wireless technology offers a more practical and patient-friendly alternative by not requiring invasive surgery for installation or removal, potentially changing the face of stomach electrical stimulation therapy.

Key Players Shaping the Gastric Electrical Stimulators Market

Prominent manufacturers of stomach electrical stimulators include Medtronic Plc., IntraPace Inc., ReShape Lifesciences, Inc., Changzhou Ruishen Medical Equipment Co, Ltd, ANS, EnteroMedics, MetaCure, Stryker Corporation, Philips.

These organizations leading the development of stomach electrical stimulators are carefully navigating the market environment using various strategies. These cover a broad range of tactics, including, but not limited to, introducing novel products, obtaining regulatory approvals, forming strategic alliances, working together, pursuing acquisitions, and merging.

These coordinated efforts demonstrate their dedication to boosting sales and getting a clear competitive advantage in the global market for stomach electrical stimulators.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 6.1% from 2023 to 2033
Base Year for Estimation	2022
Market Value in 2023	USD 240.6 million
Market Value in 2033	USD 433.8 million
Historical Data	2016 to 2022
Forecast Period	2023 to 2033
Quantitative Units	Revenue in USD million, and CAGR from 2023 to 2033
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Type, Application, End Users, Region
Regions Covered	North America; Latin America; Europe; Asia Pacific; The Middle East & Africa
Key Countries Profiled	United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, China, Japan, South Korea, Malaysia, Singapore, Australia, New Zealand, GCC, South Africa, Israel
Key Companies Profiled	Medtronic Plc.; IntraPace Inc.; ReShape Lifesciences Inc.; Changzhou Ruishen Medical Equipment Co. Ltd.; Chentao Medical Equipment; Rishena Co. Ltd.; Enterra TM
Customization	Available Upon Request

Key Segments of Gastric Electrical Stimulators Industry Survey

By Type:

• High Frequency
• Low Frequency

By Application:

• Gastroparesis
• Obesity

By End User:

• Hospitals
• Ambulatory Surgical Centers
• Other End Users

By Region:

• North America
• Latin America
• Europe
• Asia Pacific
• The Middle East & Africa

Frequently Asked Questions

What is the Current Growth Outlook for Gastric Electrical Stimulators Market?

The gastric electrical stimulators market is estimated to reach USD 240.6 million in 2023.

What Growth Rate is Projected for the Market from 2023 to 2033?

The market is expected to record a CAGR of 6.1% during the forecast period.

How Big will be the Gastric Electrical Stimulators Market by 2033?

The gastric electrical stimulators market is anticipated to be worth USD 433.8 million by 2033.

Which are Some Notable Companies in Gastric Electrical Stimulators?

Leading manufacturers include Medtronic Plc., IntraPace Inc., and ReShape Lifesciences, Inc.

Which are the Key Asian Countries in the Gastric Electrical Stimulators Market?

India, Japan, and China are the leading Asian countries in the market.